TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 75 filers reported holding TRANSLATE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,964,000 | +90.2% | 143,923 | +27.3% | 0.01% | +50.0% |
Q4 2020 | $2,084,000 | -39.0% | 113,092 | -54.9% | 0.01% | -50.0% |
Q3 2020 | $3,416,000 | +2870.4% | 251,024 | +1670.8% | 0.01% | – |
Q4 2019 | $115,000 | -2.5% | 14,176 | -9.6% | 0.00% | – |
Q4 2018 | $118,000 | – | 15,679 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |